Search Results 521-530 of 2827 for 必应搜索引擎留痕咨询邮箱：lgooxc@hotmail.com

  1. Coordinated Vulnerability Disclosure Program Terms - Mayo Clinic

    This is a legal agreement. By submitting a report of a security vulnerability or by accessing or using any of the foregoing properties, you are indicating ...

  2. Quantitative Muscle Ultrasound – Normal values and Development of a Neuromuscular Disease Database - Mayo Clinic

    About this study. The purpose of this study is to. To develop a database of normal values for muscle thickness and echo-intensity in American children and ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. Safety and Efficacy of VB-111 in Subjects with Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases - Mayo Clinic

    About this study. The purpose of this study is to determine the safety and efficacy of IDN-6556 compared to placebo in patients with diagnosed fat deposits ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis - Mayo Clinic

    This study is to determine the efficacy of momelotinib (MMB) versus ruxolitinib in participants with primary myelofibrosis (PMF) or post-polycythemia vera or ...

  10. Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

    Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Drugs used in ...